drugset / Trial / NCT04033562

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

NCT04033562 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Pregnant women with a history of opioid use disorder, chronic opioid use or those who are on medication assisted treatment will be randomly assigned to receive either a sub-fascial continuous infusion of bupivacaine or lidocaine/menthol patch after Cesarean delivery. Post-operative pain scores and opioid usage in the post-operative period will be recorded.

Timeline

Start
2020-01-15
Primary completion
2021-05-17
Completion
2021-05-17

Outcome

Outcome not reported

Stopped (Enrollment): “limited enrollment and unable to enroll subjects to reach statistical significance”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 3.6 % Topical